Fynomenol Co., Ltd. is a Company Limited, established on 23 Jun 2023 and registered in Samutprakan, Thailand. The Company’s principal business is other management consultancy activities, not elsewhere classified. Fynomenol Co., Ltd. has been operating for 3 years and its current status is Active.
Profile
Company DetailsCompany record
- Legal name
- Fynomenol Co., Ltd.
- Registration number
- 0115566019721
- Entity type
- Company Limited
- Status
- Active
- Registered date
- 23 Jun 2023
- Registered capital (THB)
- THB 1,000,000
- Industry group
- Others
- TSIC activity
- Other management consultancy activities, not elsewhere classified
Contact DetailsRegistered contact information
- Registered address
- 88/86, Moo 4, The City Sathorn- Suksawat, Bang Phung, Phra Pradaeng, Samut Prakan 10130
- Operational address
- Locked🔒
- Website
- Locked🔒
- Telephone
- Locked🔒
People
ManagementRecorded directors and signatory
- Anchana PhongsuwanDirector
ShareholderShareholding of Fynomenol Co., Ltd.
Ownership records and shareholder relationships require premium access.
- ✓Shareholder names and holdings
- ✓Ownership percentages and changes
Financial
Credit RatingCredit rating for Fynomenol Co., Ltd.
Credit assessment and supporting financial indicators require premium access.
- ✓Credit rating and payment profile
- ✓Financial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Fynomenol Co., Ltd.
Government ownership, control, and politically exposed person links require premium access.
- ✓Government ownership and control checks
- ✓Politically exposed person links
LitigationLitigation checks for Fynomenol Co., Ltd.
Court records and material dispute intelligence require premium access.
- ✓Civil and commercial court records
- ✓Case status and material outcomes
RegulatoryRegulatory checks for Fynomenol Co., Ltd.
Regulatory actions, sanctions, and compliance findings require premium access.
- ✓Regulatory actions and sanctions
- ✓Licence and compliance findings
Adverse MediaAdverse media checks for Fynomenol Co., Ltd.
Source-screened media coverage and reputational risk signals require premium access.
- ✓Source-screened media coverage
- ✓Material allegations and reputational signals